A new method with variable injection parameters in contrast-enhanced CT: a phantom study for evaluating an aortic peak enhancement

被引:1
|
作者
Terasawa K. [1 ,2 ]
Maruyama A. [3 ]
Tsukimata T. [1 ]
机构
[1] Central Radiology Department, Nagano Red Cross Hospital, 5-22-1, Wakasato, Nagano-shi, 380-8582, Nagano
[2] Graduate School of Health Science, Suzuka University of Medical Science, 1001-1, Kishioka-cho, Suzuka-shi, 510-0293, Mie
[3] Department of Radiology, Nagano Red Cross Hospital, Nagano
关键词
Contrast enhancement; Contrast material; Time-enhancement curve (TEC); Variable injection method (VIM); Variation factor (VF);
D O I
10.1007/s12194-015-0314-5
中图分类号
学科分类号
摘要
Contrast-enhanced CT employs a standard uniphasic single-injection method (SIM), wherein administration is based on two parameters: the iodine administration rate (mgI/s) and the injection duration (s). However, as the SIM uses a fixed iodine administration rate, only a uniform contrast enhancement can be achieved with this method. The iodine administration rate can be increased only by increasing the iodine dose or shortening the injection duration, and no arbitrary adjustments can be made to the peak enhancement characteristics of the time-enhancement curves (TECs) at the fixed injection parameters used in the SIM. To address this problem, we developed a variable injection method (VIM) with a new parameter, the variation factor (VF), to adjust the TECs. A phantom study with the VIM indicated that arbitrary adjustments to the iodine administration rate could be made without changing the injection duration or increasing the iodine load. In our study, VFs of 0.3 and 0.5, which showed earlier achievement of peak enhancements, showed better temporal separation between arterial vasculature and parenchyma or the venous vasculature than that obtained with the SIM. The higher peak enhancement provided by the VF of 0.3 was also considered to improve the contrast in qualitative diagnostic examinations. A VF of 0.5 increased the duration of the enhancement and was considered to produce stable enhancement of contrast in vascular investigations. The VF is now an essential parameter, and the VIM is useful as a reasonable contrast method that may contribute to both improved visualization and improvement in the accuracy of morphologic diagnosis. © 2015, Japanese Society of Radiological Technology and Japan Society of Medical Physics.
引用
收藏
页码:248 / 257
页数:9
相关论文
共 50 条
  • [41] Fast kVp-switching dual energy contrast-enhanced thorax and cardiac CT: A phantom study on the accuracy of iodine concentration and effective atomic number measurement
    Papadakis, Antonios E.
    Damilakis, John
    MEDICAL PHYSICS, 2017, 44 (09) : 4724 - 4735
  • [42] Multiphasic contrast-enhanced multidetector-row CT of liver: Contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients' body-weight-tailored dose of contrast material
    Ichikawa, T
    Erturk, SM
    Araki, T
    EUROPEAN JOURNAL OF RADIOLOGY, 2006, 58 (02) : 165 - 176
  • [43] Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
    Joline S. W. Lind
    Martijn R. Meijerink
    Anne-Marie C. Dingemans
    Cornelis van Kuijk
    Michel C. Öllers
    Dirk de Ruysscher
    Pieter E. Postmus
    Egbert F. Smit
    European Radiology, 2010, 20 : 2890 - 2898
  • [44] Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
    Lind, Joline S. W.
    Meijerink, Martijn R.
    Dingemans, Anne-Marie C.
    van Kuijk, Cornelis
    Ollers, Michel C.
    de Ruysscher, Dirk
    Postmus, Pieter E.
    Smit, Egbert F.
    EUROPEAN RADIOLOGY, 2010, 20 (12) : 2890 - 2898
  • [45] DYNAMIC CONTRAST-ENHANCED CT IN PATIENTS TREATED WITH SORAFENIB AND ERLOTINIB FOR NON-SMALL CELL LUNG CANCER: A NEW METHOD TO MONITOR TREATMENT?
    Lind, J. S. W.
    Meijerink, M. R.
    Dingemans, A. C.
    van Kuijk, C.
    Ollers, M.
    De Ruysscher, D.
    Postmus, P. E.
    Smit, E. F.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S63 - S63
  • [46] A new method to combine contrast-enhanced magnetic resonance imaging during live ultrasound of the breast using volume navigation technique: A study for evaluating feasibility, accuracy and reproducibility in healthy volunteers
    Fausto, Alfonso
    Rizzatto, Giorgio
    Preziosa, Alessandro
    Gaburro, Luca
    Washburn, Michael J.
    Rubello, Domenico
    Volterrani, Luca
    EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (03) : E332 - E337
  • [47] The Efficacy of Transarterial Chemoembolization for Small Hepatic Nodules with Atypical Enhancement on Contrast-enhanced CT but Typical Enhancement on Gadoxetic Acid-enhanced MRI in Chronic Liver Disease Patients: A Post Hoc Analysis of Prospective Study
    Kwon, Jung Hee
    Lee, Jeong-Hoon
    Cho, Eun Ju
    Lee, Yun Bin
    Cho, Yuri
    Lee, Dong Hyeon
    Lee, Minjong
    Yoo, Jeong-Ju
    Choi, Won-mook
    Yu, Su Jong
    Lee, Jeong Min
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    HEPATOLOGY, 2012, 56 : 482A - 482A
  • [48] Contrast-Enhanced Ultrasound as a New Investigative Tool in Diagnostic Imaging of Muscle Injuries-A Pilot Study Evaluating Conventional Ultrasound, CEUS, and Findings in MRI
    Hotfiel, Thilo
    Heiss, Rafael
    Swoboda, Bernd
    Kellermann, Marion
    Gelse, Kolja
    Grim, Casper
    Strobel, Deike
    Wildner, Dane
    CLINICAL JOURNAL OF SPORT MEDICINE, 2018, 28 (04): : 332 - 338
  • [49] Discriminating atypical parotid carcinoma and pleomorphic adenoma utilizing extracellular volume fraction and arterial enhancement fraction derived from contrast-enhanced CT imaging: A multicenter study
    Xu, Zhen-Yu
    Huang, Lin-Wen
    Yang, Yun-Jun
    Cai, Zhi-Ping
    Chen, Mei-Lin
    Lu, Rui-Liang
    Ouyang, Yong-Xi
    Hong, Zhen-Kai
    Huang, Wei-Jun
    Xu, Zhi-Feng
    CANCER MEDICINE, 2024, 13 (12):
  • [50] Feasibility study of a new volume navigation system-guided breast biopsy method for incidental enhancing lesions detected by breast contrast-enhanced magnetic resonance imaging
    Takahashi, M.
    Jinno, H.
    Hayashida, T.
    Nemoto, M.
    Tanimoto, A.
    Kitagawa, Y.
    CANCER RESEARCH, 2012, 72